nodes	percent_of_prediction	percent_of_DWPC	metapath
Ursodeoxycholic acid—CYP2E1—Fingolimod—multiple sclerosis	0.112	0.168	CbGbCtD
Ursodeoxycholic acid—SLCO1A2—Prednisolone—multiple sclerosis	0.0869	0.13	CbGbCtD
Ursodeoxycholic acid—SLCO1A2—Prednisone—multiple sclerosis	0.0821	0.123	CbGbCtD
Ursodeoxycholic acid—ABCB11—Dexamethasone—multiple sclerosis	0.0808	0.121	CbGbCtD
Ursodeoxycholic acid—ABCC4—Methotrexate—multiple sclerosis	0.0574	0.0858	CbGbCtD
Ursodeoxycholic acid—CYP2E1—Mitoxantrone—multiple sclerosis	0.0528	0.079	CbGbCtD
Ursodeoxycholic acid—SLCO1A2—Dexamethasone—multiple sclerosis	0.0512	0.0766	CbGbCtD
Ursodeoxycholic acid—ABCC2—Dexamethasone—multiple sclerosis	0.0425	0.0635	CbGbCtD
Ursodeoxycholic acid—SLCO1A2—Methotrexate—multiple sclerosis	0.0412	0.0616	CbGbCtD
Ursodeoxycholic acid—ABCC2—Methotrexate—multiple sclerosis	0.0341	0.051	CbGbCtD
Ursodeoxycholic acid—CYP2E1—Dexamethasone—multiple sclerosis	0.0274	0.0409	CbGbCtD
Ursodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00297	0.0351	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00297	0.0351	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00193	0.0228	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00193	0.0228	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Recycling of bile acids and salts—ALB—multiple sclerosis	0.00191	0.0225	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00189	0.0223	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00189	0.0223	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00187	0.0221	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00169	0.02	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00154	0.0182	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00154	0.0182	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00153	0.0181	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00153	0.0181	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00147	0.0174	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00147	0.0174	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00135	0.016	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Irinotecan Pathway—BCHE—multiple sclerosis	0.0013	0.0154	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Recycling of bile acids and salts—ALB—multiple sclerosis	0.00123	0.0145	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—VDR—multiple sclerosis	0.00121	0.0142	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.00112	0.0132	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Recycling of bile acids and salts—ALB—multiple sclerosis	0.00111	0.0132	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.0011	0.013	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00101	0.0119	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000997	0.0118	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000992	0.0117	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Ectoderm Differentiation—AHI1—multiple sclerosis	0.000989	0.0117	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000972	0.0115	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000917	0.0108	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000917	0.0108	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Endogenous sterols—POMC—multiple sclerosis	0.000914	0.0108	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000837	0.00989	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Transport of organic anions—ALB—multiple sclerosis	0.000816	0.00965	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Biological oxidations—CYP27B1—multiple sclerosis	0.000812	0.00961	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Biological oxidations—CYP24A1—multiple sclerosis	0.000812	0.00961	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Recycling of bile acids and salts—ALB—multiple sclerosis	0.000724	0.00856	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet degranulation—PLEK—multiple sclerosis	0.000716	0.00846	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000703	0.00831	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.000682	0.00806	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000642	0.00759	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000632	0.00747	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Recycling of bile acids and salts—ALB—multiple sclerosis	0.000605	0.00715	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000599	0.00708	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000599	0.00708	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000582	0.00688	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000582	0.00688	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000582	0.00688	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000576	0.00681	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000574	0.00679	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000574	0.00679	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000546	0.00646	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000534	0.00631	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000534	0.00631	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00048	0.00568	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.000478	0.00565	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000472	0.00558	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000472	0.00558	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.000446	0.00527	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000424	0.00502	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000414	0.00489	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—SRM—multiple sclerosis	0.000379	0.00448	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000379	0.00448	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000344	0.00407	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000344	0.00407	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000344	0.00407	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000341	0.00403	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—SRM—multiple sclerosis	0.000338	0.00399	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000327	0.00387	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000319	0.00377	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000318	0.00375	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000316	0.00374	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000312	0.00369	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000312	0.00369	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000303	0.00358	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.0003	0.00355	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000289	0.00342	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—ZNF746—multiple sclerosis	0.000277	0.00328	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—CYP24A1—multiple sclerosis	0.000267	0.00315	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—CYP27B1—multiple sclerosis	0.000267	0.00315	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—MERTK—multiple sclerosis	0.000265	0.00313	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—SELPLG—multiple sclerosis	0.000265	0.00313	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—CD58—multiple sclerosis	0.000265	0.00313	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000261	0.00308	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000258	0.00305	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—PTBP1—multiple sclerosis	0.000254	0.003	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000251	0.00296	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000251	0.00296	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000247	0.00292	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000247	0.00292	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—GPC5—multiple sclerosis	0.000244	0.00289	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000242	0.00286	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—CYP27B1—multiple sclerosis	0.000238	0.00281	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—CYP24A1—multiple sclerosis	0.000238	0.00281	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000232	0.00275	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—SRM—multiple sclerosis	0.000218	0.00257	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—GPC5—multiple sclerosis	0.000218	0.00257	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000203	0.0024	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000203	0.0024	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—RRM1—multiple sclerosis	0.000202	0.00239	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—SRM—multiple sclerosis	0.000197	0.00233	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—HNRNPA1—multiple sclerosis	0.000192	0.00227	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—U2AF2—multiple sclerosis	0.000192	0.00227	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000191	0.00226	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000187	0.00221	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Biological oxidations—POMC—multiple sclerosis	0.000183	0.00216	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00018	0.00213	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—RRM1—multiple sclerosis	0.00018	0.00213	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet degranulation—ALB—multiple sclerosis	0.00018	0.00213	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—PGR—multiple sclerosis	0.000174	0.00205	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000173	0.00205	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—multiple sclerosis	0.000172	0.00203	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000169	0.002	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000169	0.002	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000169	0.002	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—PLEK—multiple sclerosis	0.000164	0.00194	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000158	0.00186	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000157	0.00185	CbGpPWpGaD
Ursodeoxycholic acid—Sweating—Methotrexate—multiple sclerosis	0.000156	0.000631	CcSEcCtD
Ursodeoxycholic acid—Infection—Methylprednisolone—multiple sclerosis	0.000155	0.00063	CcSEcCtD
Ursodeoxycholic acid—Haematuria—Methotrexate—multiple sclerosis	0.000155	0.000628	CcSEcCtD
Ursodeoxycholic acid—Shock—Triamcinolone—multiple sclerosis	0.000154	0.000626	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Prednisolone—multiple sclerosis	0.000154	0.000626	CcSEcCtD
Ursodeoxycholic acid—Alopecia—Prednisone—multiple sclerosis	0.000154	0.000625	CcSEcCtD
Ursodeoxycholic acid—Shock—Methylprednisolone—multiple sclerosis	0.000154	0.000624	CcSEcCtD
Ursodeoxycholic acid—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000154	0.000623	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000153	0.000622	CcSEcCtD
Ursodeoxycholic acid—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000153	0.000622	CcSEcCtD
Ursodeoxycholic acid—Loss of consciousness—Betamethasone—multiple sclerosis	0.000153	0.000622	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—CYP24A1—multiple sclerosis	0.000153	0.00181	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—CYP27B1—multiple sclerosis	0.000153	0.00181	CbGpPWpGaD
Ursodeoxycholic acid—Epistaxis—Methotrexate—multiple sclerosis	0.000153	0.000621	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000153	0.000621	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Prednisolone—multiple sclerosis	0.000153	0.000621	CcSEcCtD
Ursodeoxycholic acid—Tachycardia—Triamcinolone—multiple sclerosis	0.000153	0.000621	CcSEcCtD
Ursodeoxycholic acid—Nausea—Azathioprine—multiple sclerosis	0.000153	0.000619	CcSEcCtD
Ursodeoxycholic acid—Tachycardia—Methylprednisolone—multiple sclerosis	0.000153	0.000619	CcSEcCtD
Ursodeoxycholic acid—Skin disorder—Methylprednisolone—multiple sclerosis	0.000152	0.000616	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Gene Expression—ZFP36L1—multiple sclerosis	0.000152	0.0018	CbGpPWpGaD
Ursodeoxycholic acid—Malnutrition—Prednisone—multiple sclerosis	0.000152	0.000616	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000152	0.000615	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000151	0.000614	CcSEcCtD
Ursodeoxycholic acid—Convulsion—Dexamethasone—multiple sclerosis	0.000151	0.000613	CcSEcCtD
Ursodeoxycholic acid—Convulsion—Betamethasone—multiple sclerosis	0.000151	0.000613	CcSEcCtD
Ursodeoxycholic acid—Hypertension—Dexamethasone—multiple sclerosis	0.000151	0.000611	CcSEcCtD
Ursodeoxycholic acid—Hypertension—Betamethasone—multiple sclerosis	0.000151	0.000611	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00015	0.00177	CbGpPWpGaD
Ursodeoxycholic acid—Asthenia—Mitoxantrone—multiple sclerosis	0.000149	0.000605	CcSEcCtD
Ursodeoxycholic acid—Myalgia—Betamethasone—multiple sclerosis	0.000148	0.000602	CcSEcCtD
Ursodeoxycholic acid—Myalgia—Dexamethasone—multiple sclerosis	0.000148	0.000602	CcSEcCtD
Ursodeoxycholic acid—Discomfort—Betamethasone—multiple sclerosis	0.000147	0.000595	CcSEcCtD
Ursodeoxycholic acid—Discomfort—Dexamethasone—multiple sclerosis	0.000147	0.000595	CcSEcCtD
Ursodeoxycholic acid—Haemoglobin—Methotrexate—multiple sclerosis	0.000147	0.000594	CcSEcCtD
Ursodeoxycholic acid—Hypotension—Methylprednisolone—multiple sclerosis	0.000146	0.000593	CcSEcCtD
Ursodeoxycholic acid—Pain—Prednisolone—multiple sclerosis	0.000146	0.000591	CcSEcCtD
Ursodeoxycholic acid—Haemorrhage—Methotrexate—multiple sclerosis	0.000146	0.000591	CcSEcCtD
Ursodeoxycholic acid—Pharyngitis—Methotrexate—multiple sclerosis	0.000145	0.000587	CcSEcCtD
Ursodeoxycholic acid—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000144	0.000584	CcSEcCtD
Ursodeoxycholic acid—Urethral disorder—Methotrexate—multiple sclerosis	0.000143	0.00058	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000143	0.000579	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000143	0.000578	CcSEcCtD
Ursodeoxycholic acid—Oedema—Betamethasone—multiple sclerosis	0.000142	0.000577	CcSEcCtD
Ursodeoxycholic acid—Oedema—Dexamethasone—multiple sclerosis	0.000142	0.000577	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000142	0.000577	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Triamcinolone—multiple sclerosis	0.000142	0.000575	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000142	0.00168	CbGpPWpGaD
Ursodeoxycholic acid—Insomnia—Methylprednisolone—multiple sclerosis	0.000142	0.000574	CcSEcCtD
Ursodeoxycholic acid—Infection—Betamethasone—multiple sclerosis	0.000141	0.000573	CcSEcCtD
Ursodeoxycholic acid—Infection—Dexamethasone—multiple sclerosis	0.000141	0.000573	CcSEcCtD
Ursodeoxycholic acid—Ill-defined disorder—Prednisone—multiple sclerosis	0.000141	0.000571	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Triamcinolone—multiple sclerosis	0.000141	0.000571	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Prednisolone—multiple sclerosis	0.000141	0.00057	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000141	0.00057	CcSEcCtD
Ursodeoxycholic acid—Visual impairment—Methotrexate—multiple sclerosis	0.000141	0.00057	CcSEcCtD
Ursodeoxycholic acid—Anaemia—Prednisone—multiple sclerosis	0.00014	0.000569	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—GPC5—multiple sclerosis	0.00014	0.00166	CbGpPWpGaD
Ursodeoxycholic acid—Shock—Betamethasone—multiple sclerosis	0.00014	0.000568	CcSEcCtD
Ursodeoxycholic acid—Shock—Dexamethasone—multiple sclerosis	0.00014	0.000568	CcSEcCtD
Ursodeoxycholic acid—Dyspnoea—Triamcinolone—multiple sclerosis	0.00014	0.000567	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.00014	0.00165	CbGpPWpGaD
Ursodeoxycholic acid—Nervous system disorder—Betamethasone—multiple sclerosis	0.00014	0.000566	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00014	0.000566	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000139	0.000565	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000139	0.000565	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—CYP24A1—multiple sclerosis	0.000139	0.00164	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—CYP27B1—multiple sclerosis	0.000139	0.00164	CbGpPWpGaD
Ursodeoxycholic acid—Tachycardia—Dexamethasone—multiple sclerosis	0.000139	0.000563	CcSEcCtD
Ursodeoxycholic acid—Tachycardia—Betamethasone—multiple sclerosis	0.000139	0.000563	CcSEcCtD
Ursodeoxycholic acid—Angioedema—Prednisone—multiple sclerosis	0.000139	0.000563	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Triamcinolone—multiple sclerosis	0.000138	0.00056	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000138	0.000559	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000138	0.000558	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000138	0.000558	CcSEcCtD
Ursodeoxycholic acid—Malaise—Prednisone—multiple sclerosis	0.000137	0.000555	CcSEcCtD
Ursodeoxycholic acid—Vertigo—Prednisone—multiple sclerosis	0.000136	0.000553	CcSEcCtD
Ursodeoxycholic acid—Eye disorder—Methotrexate—multiple sclerosis	0.000136	0.000552	CcSEcCtD
Ursodeoxycholic acid—Syncope—Prednisone—multiple sclerosis	0.000136	0.000552	CcSEcCtD
Ursodeoxycholic acid—Tinnitus—Methotrexate—multiple sclerosis	0.000136	0.000551	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000136	0.00161	CbGpPWpGaD
Ursodeoxycholic acid—Anorexia—Dexamethasone—multiple sclerosis	0.000136	0.00055	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Betamethasone—multiple sclerosis	0.000136	0.00055	CcSEcCtD
Ursodeoxycholic acid—Urticaria—Prednisolone—multiple sclerosis	0.000136	0.000549	CcSEcCtD
Ursodeoxycholic acid—Cardiac disorder—Methotrexate—multiple sclerosis	0.000135	0.000549	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Triamcinolone—multiple sclerosis	0.000135	0.000548	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Methylprednisolone—multiple sclerosis	0.000135	0.000547	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000135	0.00159	CbGpPWpGaD
Ursodeoxycholic acid—Pain—Triamcinolone—multiple sclerosis	0.000134	0.000544	CcSEcCtD
Ursodeoxycholic acid—Loss of consciousness—Prednisone—multiple sclerosis	0.000133	0.000541	CcSEcCtD
Ursodeoxycholic acid—Hypotension—Dexamethasone—multiple sclerosis	0.000133	0.000539	CcSEcCtD
Ursodeoxycholic acid—Hypotension—Betamethasone—multiple sclerosis	0.000133	0.000539	CcSEcCtD
Ursodeoxycholic acid—Angiopathy—Methotrexate—multiple sclerosis	0.000132	0.000536	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Mitoxantrone—multiple sclerosis	0.000132	0.000536	CcSEcCtD
Ursodeoxycholic acid—Immune system disorder—Methotrexate—multiple sclerosis	0.000132	0.000534	CcSEcCtD
Ursodeoxycholic acid—Convulsion—Prednisone—multiple sclerosis	0.000132	0.000534	CcSEcCtD
Ursodeoxycholic acid—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000131	0.000533	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000131	0.00155	CbGpPWpGaD
Ursodeoxycholic acid—Hypertension—Prednisone—multiple sclerosis	0.000131	0.000532	CcSEcCtD
Ursodeoxycholic acid—Rash—Mitoxantrone—multiple sclerosis	0.000131	0.000532	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Mitoxantrone—multiple sclerosis	0.000131	0.000531	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000131	0.00155	CbGpPWpGaD
Ursodeoxycholic acid—Chills—Methotrexate—multiple sclerosis	0.000131	0.00053	CcSEcCtD
Ursodeoxycholic acid—Headache—Mitoxantrone—multiple sclerosis	0.00013	0.000528	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00013	0.000526	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00013	0.000526	CcSEcCtD
Ursodeoxycholic acid—Myalgia—Prednisone—multiple sclerosis	0.000129	0.000524	CcSEcCtD
Ursodeoxycholic acid—Arthralgia—Prednisone—multiple sclerosis	0.000129	0.000524	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000129	0.000524	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000129	0.000523	CcSEcCtD
Ursodeoxycholic acid—Alopecia—Methotrexate—multiple sclerosis	0.000129	0.000522	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Dexamethasone—multiple sclerosis	0.000129	0.000522	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Betamethasone—multiple sclerosis	0.000129	0.000522	CcSEcCtD
Ursodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000128	0.000521	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—SRM—multiple sclerosis	0.000128	0.00152	CbGpPWpGaD
Ursodeoxycholic acid—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000128	0.000519	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Dexamethasone—multiple sclerosis	0.000128	0.000518	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Betamethasone—multiple sclerosis	0.000128	0.000518	CcSEcCtD
Ursodeoxycholic acid—Discomfort—Prednisone—multiple sclerosis	0.000128	0.000518	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—GPC5—multiple sclerosis	0.000127	0.0015	CbGpPWpGaD
Ursodeoxycholic acid—Malnutrition—Methotrexate—multiple sclerosis	0.000127	0.000515	CcSEcCtD
Ursodeoxycholic acid—Hypersensitivity—Prednisolone—multiple sclerosis	0.000126	0.00051	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Betamethasone—multiple sclerosis	0.000125	0.000508	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Dexamethasone—multiple sclerosis	0.000125	0.000508	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Ectoderm Differentiation—CCL2—multiple sclerosis	0.000125	0.00148	CbGpPWpGaD
Ursodeoxycholic acid—Urticaria—Triamcinolone—multiple sclerosis	0.000125	0.000505	CcSEcCtD
Ursodeoxycholic acid—Urticaria—Methylprednisolone—multiple sclerosis	0.000124	0.000504	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Triamcinolone—multiple sclerosis	0.000124	0.000503	CcSEcCtD
Ursodeoxycholic acid—Oedema—Prednisone—multiple sclerosis	0.000124	0.000503	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000124	0.000502	CcSEcCtD
Ursodeoxycholic acid—Decreased appetite—Betamethasone—multiple sclerosis	0.000124	0.000502	CcSEcCtD
Ursodeoxycholic acid—Decreased appetite—Dexamethasone—multiple sclerosis	0.000124	0.000502	CcSEcCtD
Ursodeoxycholic acid—Nausea—Mitoxantrone—multiple sclerosis	0.000124	0.000501	CcSEcCtD
Ursodeoxycholic acid—Infection—Prednisone—multiple sclerosis	0.000123	0.000499	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000123	0.000498	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000123	0.000498	CcSEcCtD
Ursodeoxycholic acid—AKR1C2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000123	0.00145	CbGpPWpGaD
Ursodeoxycholic acid—Back pain—Methotrexate—multiple sclerosis	0.000123	0.000498	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Dexamethasone—multiple sclerosis	0.000123	0.000498	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Betamethasone—multiple sclerosis	0.000123	0.000498	CcSEcCtD
Ursodeoxycholic acid—Shock—Prednisone—multiple sclerosis	0.000122	0.000494	CcSEcCtD
Ursodeoxycholic acid—Pain—Betamethasone—multiple sclerosis	0.000122	0.000494	CcSEcCtD
Ursodeoxycholic acid—Pain—Dexamethasone—multiple sclerosis	0.000122	0.000494	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Prednisone—multiple sclerosis	0.000122	0.000493	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—VDR—multiple sclerosis	0.000121	0.00144	CbGpPWpGaD
Ursodeoxycholic acid—Tachycardia—Prednisone—multiple sclerosis	0.000121	0.000491	CcSEcCtD
Ursodeoxycholic acid—Skin disorder—Prednisone—multiple sclerosis	0.00012	0.000488	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.00012	0.00142	CbGpPWpGaD
Ursodeoxycholic acid—Hyperhidrosis—Prednisone—multiple sclerosis	0.00012	0.000486	CcSEcCtD
Ursodeoxycholic acid—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000119	0.00141	CbGpPWpGaD
Ursodeoxycholic acid—Anorexia—Prednisone—multiple sclerosis	0.000118	0.000479	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Gene Expression—PABPC1—multiple sclerosis	0.000118	0.00139	CbGpPWpGaD
Ursodeoxycholic acid—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000118	0.000478	CcSEcCtD
Ursodeoxycholic acid—Anaemia—Methotrexate—multiple sclerosis	0.000117	0.000476	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Betamethasone—multiple sclerosis	0.000117	0.000476	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000117	0.000476	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000116	0.000472	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000116	0.000472	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism—RRM1—multiple sclerosis	0.000116	0.00137	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—BCHE—multiple sclerosis	0.000116	0.00137	CbGpPWpGaD
Ursodeoxycholic acid—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000116	0.000469	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Hemostasis—SELE—multiple sclerosis	0.000115	0.00136	CbGpPWpGaD
Ursodeoxycholic acid—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000115	0.000468	CcSEcCtD
Ursodeoxycholic acid—Malaise—Methotrexate—multiple sclerosis	0.000114	0.000464	CcSEcCtD
Ursodeoxycholic acid—Vertigo—Methotrexate—multiple sclerosis	0.000114	0.000462	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Platelet degranulation—TGFB1—multiple sclerosis	0.000114	0.00135	CbGpPWpGaD
Ursodeoxycholic acid—Leukopenia—Methotrexate—multiple sclerosis	0.000114	0.000461	CcSEcCtD
Ursodeoxycholic acid—Urticaria—Betamethasone—multiple sclerosis	0.000113	0.000458	CcSEcCtD
Ursodeoxycholic acid—Urticaria—Dexamethasone—multiple sclerosis	0.000113	0.000458	CcSEcCtD
Ursodeoxycholic acid—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000113	0.000458	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Prednisolone—multiple sclerosis	0.000113	0.000457	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Triamcinolone—multiple sclerosis	0.000113	0.000456	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Betamethasone—multiple sclerosis	0.000113	0.000456	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Dexamethasone—multiple sclerosis	0.000113	0.000456	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Dexamethasone—multiple sclerosis	0.000113	0.000456	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Betamethasone—multiple sclerosis	0.000113	0.000456	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Methylprednisolone—multiple sclerosis	0.000112	0.000455	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Prednisone—multiple sclerosis	0.000112	0.000455	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000112	0.00132	CbGpPWpGaD
Ursodeoxycholic acid—Paraesthesia—Prednisone—multiple sclerosis	0.000111	0.000451	CcSEcCtD
Ursodeoxycholic acid—Pruritus—Triamcinolone—multiple sclerosis	0.000111	0.00045	CcSEcCtD
Ursodeoxycholic acid—Cough—Methotrexate—multiple sclerosis	0.000111	0.000449	CcSEcCtD
Ursodeoxycholic acid—Pruritus—Methylprednisolone—multiple sclerosis	0.000111	0.000449	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.000111	0.00131	CbGpPWpGaD
Ursodeoxycholic acid—Convulsion—Methotrexate—multiple sclerosis	0.00011	0.000446	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.00011	0.00129	CbGpPWpGaD
Ursodeoxycholic acid—Dyspepsia—Prednisone—multiple sclerosis	0.000109	0.000442	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	0.000109	0.00128	CbGpPWpGaD
Ursodeoxycholic acid—Myalgia—Methotrexate—multiple sclerosis	0.000108	0.000438	CcSEcCtD
Ursodeoxycholic acid—Arthralgia—Methotrexate—multiple sclerosis	0.000108	0.000438	CcSEcCtD
Ursodeoxycholic acid—Chest pain—Methotrexate—multiple sclerosis	0.000108	0.000438	CcSEcCtD
Ursodeoxycholic acid—Decreased appetite—Prednisone—multiple sclerosis	0.000108	0.000437	CcSEcCtD
Ursodeoxycholic acid—Rash—Prednisolone—multiple sclerosis	0.000108	0.000436	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Prednisolone—multiple sclerosis	0.000107	0.000436	CcSEcCtD
Ursodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000107	0.000435	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000107	0.000434	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism—SRM—multiple sclerosis	0.000107	0.00127	CbGpPWpGaD
Ursodeoxycholic acid—Fatigue—Prednisone—multiple sclerosis	0.000107	0.000433	CcSEcCtD
Ursodeoxycholic acid—Headache—Prednisolone—multiple sclerosis	0.000107	0.000433	CcSEcCtD
Ursodeoxycholic acid—Discomfort—Methotrexate—multiple sclerosis	0.000107	0.000433	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Gene Expression—RPL5—multiple sclerosis	0.000106	0.00126	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000106	0.00125	CbGpPWpGaD
Ursodeoxycholic acid—Constipation—Prednisone—multiple sclerosis	0.000106	0.00043	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism—RRM1—multiple sclerosis	0.000105	0.00124	CbGpPWpGaD
Ursodeoxycholic acid—Confusional state—Methotrexate—multiple sclerosis	0.000104	0.000424	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000104	0.00123	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000104	0.00123	CbGpPWpGaD
Ursodeoxycholic acid—Dizziness—Triamcinolone—multiple sclerosis	0.000104	0.000421	CcSEcCtD
Ursodeoxycholic acid—SLC10A2—Metabolism—BCHE—multiple sclerosis	0.000104	0.00122	CbGpPWpGaD
Ursodeoxycholic acid—Dizziness—Methylprednisolone—multiple sclerosis	0.000104	0.00042	CcSEcCtD
Ursodeoxycholic acid—Infection—Methotrexate—multiple sclerosis	0.000103	0.000417	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Prednisone—multiple sclerosis	0.000102	0.000414	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Dexamethasone—multiple sclerosis	0.000102	0.000414	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Betamethasone—multiple sclerosis	0.000102	0.000414	CcSEcCtD
Ursodeoxycholic acid—Nervous system disorder—Methotrexate—multiple sclerosis	0.000102	0.000412	CcSEcCtD
Ursodeoxycholic acid—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000101	0.000411	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000101	0.000411	CcSEcCtD
Ursodeoxycholic acid—Nausea—Prednisolone—multiple sclerosis	0.000101	0.000411	CcSEcCtD
Ursodeoxycholic acid—Pruritus—Dexamethasone—multiple sclerosis	0.000101	0.000408	CcSEcCtD
Ursodeoxycholic acid—Pruritus—Betamethasone—multiple sclerosis	0.000101	0.000408	CcSEcCtD
Ursodeoxycholic acid—Skin disorder—Methotrexate—multiple sclerosis	0.000101	0.000408	CcSEcCtD
Ursodeoxycholic acid—Hyperhidrosis—Methotrexate—multiple sclerosis	0.0001	0.000406	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Triamcinolone—multiple sclerosis	9.97e-05	0.000404	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Methylprednisolone—multiple sclerosis	9.95e-05	0.000404	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.9e-05	0.00117	CbGpPWpGaD
Ursodeoxycholic acid—Rash—Triamcinolone—multiple sclerosis	9.89e-05	0.000401	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Triamcinolone—multiple sclerosis	9.88e-05	0.000401	CcSEcCtD
Ursodeoxycholic acid—Anorexia—Methotrexate—multiple sclerosis	9.87e-05	0.0004	CcSEcCtD
Ursodeoxycholic acid—Rash—Methylprednisolone—multiple sclerosis	9.87e-05	0.0004	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Methylprednisolone—multiple sclerosis	9.86e-05	0.0004	CcSEcCtD
Ursodeoxycholic acid—Urticaria—Prednisone—multiple sclerosis	9.85e-05	0.000399	CcSEcCtD
Ursodeoxycholic acid—Headache—Triamcinolone—multiple sclerosis	9.83e-05	0.000398	CcSEcCtD
Ursodeoxycholic acid—Headache—Methylprednisolone—multiple sclerosis	9.81e-05	0.000398	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Prednisone—multiple sclerosis	9.8e-05	0.000397	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Prednisone—multiple sclerosis	9.8e-05	0.000397	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Dexamethasone—multiple sclerosis	9.74e-05	0.000395	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Betamethasone—multiple sclerosis	9.74e-05	0.000395	CcSEcCtD
Ursodeoxycholic acid—Hypotension—Methotrexate—multiple sclerosis	9.68e-05	0.000392	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	9.67e-05	0.00114	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.45e-05	0.00112	CbGpPWpGaD
Ursodeoxycholic acid—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	9.44e-05	0.000383	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Betamethasone—multiple sclerosis	9.41e-05	0.000382	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Dexamethasone—multiple sclerosis	9.41e-05	0.000382	CcSEcCtD
Ursodeoxycholic acid—Insomnia—Methotrexate—multiple sclerosis	9.37e-05	0.00038	CcSEcCtD
Ursodeoxycholic acid—Nausea—Triamcinolone—multiple sclerosis	9.32e-05	0.000378	CcSEcCtD
Ursodeoxycholic acid—Paraesthesia—Methotrexate—multiple sclerosis	9.3e-05	0.000377	CcSEcCtD
Ursodeoxycholic acid—Nausea—Methylprednisolone—multiple sclerosis	9.3e-05	0.000377	CcSEcCtD
Ursodeoxycholic acid—Dyspnoea—Methotrexate—multiple sclerosis	9.24e-05	0.000374	CcSEcCtD
Ursodeoxycholic acid—Somnolence—Methotrexate—multiple sclerosis	9.21e-05	0.000373	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.17e-05	0.00108	CbGpPWpGaD
Ursodeoxycholic acid—Hypersensitivity—Prednisone—multiple sclerosis	9.13e-05	0.00037	CcSEcCtD
Ursodeoxycholic acid—Dyspepsia—Methotrexate—multiple sclerosis	9.12e-05	0.00037	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Dexamethasone—multiple sclerosis	9.05e-05	0.000367	CcSEcCtD
Ursodeoxycholic acid—Vomiting—Betamethasone—multiple sclerosis	9.05e-05	0.000367	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—CYP24A1—multiple sclerosis	9.03e-05	0.00107	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—CYP27B1—multiple sclerosis	9.03e-05	0.00107	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.01e-05	0.00107	CbGpPWpGaD
Ursodeoxycholic acid—Decreased appetite—Methotrexate—multiple sclerosis	9.01e-05	0.000365	CcSEcCtD
Ursodeoxycholic acid—Rash—Dexamethasone—multiple sclerosis	8.97e-05	0.000364	CcSEcCtD
Ursodeoxycholic acid—Rash—Betamethasone—multiple sclerosis	8.97e-05	0.000364	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Betamethasone—multiple sclerosis	8.97e-05	0.000364	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Dexamethasone—multiple sclerosis	8.97e-05	0.000364	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal disorder—Methotrexate—multiple sclerosis	8.94e-05	0.000363	CcSEcCtD
Ursodeoxycholic acid—Fatigue—Methotrexate—multiple sclerosis	8.93e-05	0.000362	CcSEcCtD
Ursodeoxycholic acid—Headache—Betamethasone—multiple sclerosis	8.92e-05	0.000362	CcSEcCtD
Ursodeoxycholic acid—Headache—Dexamethasone—multiple sclerosis	8.92e-05	0.000362	CcSEcCtD
Ursodeoxycholic acid—Asthenia—Prednisone—multiple sclerosis	8.89e-05	0.000361	CcSEcCtD
Ursodeoxycholic acid—Pain—Methotrexate—multiple sclerosis	8.86e-05	0.000359	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.83e-05	0.00104	CbGpPWpGaD
Ursodeoxycholic acid—Pruritus—Prednisone—multiple sclerosis	8.77e-05	0.000356	CcSEcCtD
Ursodeoxycholic acid—Feeling abnormal—Methotrexate—multiple sclerosis	8.54e-05	0.000346	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Prednisone—multiple sclerosis	8.48e-05	0.000344	CcSEcCtD
Ursodeoxycholic acid—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.47e-05	0.000343	CcSEcCtD
Ursodeoxycholic acid—Nausea—Dexamethasone—multiple sclerosis	8.45e-05	0.000343	CcSEcCtD
Ursodeoxycholic acid—Nausea—Betamethasone—multiple sclerosis	8.45e-05	0.000343	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Gene Expression—PGR—multiple sclerosis	8.37e-05	0.000989	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.35e-05	0.000987	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—ITGA4—multiple sclerosis	8.34e-05	0.000986	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—IFNB1—multiple sclerosis	8.28e-05	0.000979	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—GPC5—multiple sclerosis	8.26e-05	0.000977	CbGpPWpGaD
Ursodeoxycholic acid—Urticaria—Methotrexate—multiple sclerosis	8.23e-05	0.000334	CcSEcCtD
Ursodeoxycholic acid—Dizziness—Prednisone—multiple sclerosis	8.2e-05	0.000332	CcSEcCtD
Ursodeoxycholic acid—Body temperature increased—Methotrexate—multiple sclerosis	8.19e-05	0.000332	CcSEcCtD
Ursodeoxycholic acid—Abdominal pain—Methotrexate—multiple sclerosis	8.19e-05	0.000332	CcSEcCtD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.17e-05	0.000966	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	7.99e-05	0.000945	CbGpPWpGaD
Ursodeoxycholic acid—Vomiting—Prednisone—multiple sclerosis	7.88e-05	0.00032	CcSEcCtD
Ursodeoxycholic acid—Rash—Prednisone—multiple sclerosis	7.82e-05	0.000317	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Prednisone—multiple sclerosis	7.81e-05	0.000317	CcSEcCtD
Ursodeoxycholic acid—Headache—Prednisone—multiple sclerosis	7.77e-05	0.000315	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.74e-05	0.000915	CbGpPWpGaD
Ursodeoxycholic acid—Hypersensitivity—Methotrexate—multiple sclerosis	7.63e-05	0.000309	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	7.54e-05	0.000891	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	7.54e-05	0.000891	CbGpPWpGaD
Ursodeoxycholic acid—Asthenia—Methotrexate—multiple sclerosis	7.43e-05	0.000301	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	7.38e-05	0.000873	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.37e-05	0.000871	CbGpPWpGaD
Ursodeoxycholic acid—Nausea—Prednisone—multiple sclerosis	7.36e-05	0.000299	CcSEcCtD
Ursodeoxycholic acid—Pruritus—Methotrexate—multiple sclerosis	7.33e-05	0.000297	CcSEcCtD
Ursodeoxycholic acid—Diarrhoea—Methotrexate—multiple sclerosis	7.09e-05	0.000287	CcSEcCtD
Ursodeoxycholic acid—SLC10A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.06e-05	0.000834	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	7.04e-05	0.000832	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.02e-05	0.00083	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—APOE—multiple sclerosis	6.99e-05	0.000826	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—GPC5—multiple sclerosis	6.9e-05	0.000815	CbGpPWpGaD
Ursodeoxycholic acid—Dizziness—Methotrexate—multiple sclerosis	6.85e-05	0.000278	CcSEcCtD
Ursodeoxycholic acid—ABCB11—Metabolism—RRM1—multiple sclerosis	6.85e-05	0.000809	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—BCHE—multiple sclerosis	6.67e-05	0.000789	CbGpPWpGaD
Ursodeoxycholic acid—Vomiting—Methotrexate—multiple sclerosis	6.59e-05	0.000267	CcSEcCtD
Ursodeoxycholic acid—Rash—Methotrexate—multiple sclerosis	6.53e-05	0.000265	CcSEcCtD
Ursodeoxycholic acid—Dermatitis—Methotrexate—multiple sclerosis	6.53e-05	0.000265	CcSEcCtD
Ursodeoxycholic acid—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.5e-05	0.000768	CbGpPWpGaD
Ursodeoxycholic acid—Headache—Methotrexate—multiple sclerosis	6.49e-05	0.000263	CcSEcCtD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	6.48e-05	0.000766	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.4e-05	0.000756	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—APOE—multiple sclerosis	6.23e-05	0.000736	CbGpPWpGaD
Ursodeoxycholic acid—Nausea—Methotrexate—multiple sclerosis	6.15e-05	0.000249	CcSEcCtD
Ursodeoxycholic acid—CYP2E1—Metabolism—SRM—multiple sclerosis	6.08e-05	0.000719	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.08e-05	0.000719	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—BCHE—multiple sclerosis	6.05e-05	0.000715	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—POMC—multiple sclerosis	6e-05	0.00071	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	5.94e-05	0.000702	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—VDR—multiple sclerosis	5.85e-05	0.000691	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—RRM1—multiple sclerosis	5.71e-05	0.000676	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—IL2RA—multiple sclerosis	5.7e-05	0.000673	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Biological oxidations—POMC—multiple sclerosis	5.64e-05	0.000667	CbGpPWpGaD
Ursodeoxycholic acid—AKR1C2—Metabolism—ALB—multiple sclerosis	5.47e-05	0.000647	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—POMC—multiple sclerosis	5.35e-05	0.000633	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.31e-05	0.000628	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	5.05e-05	0.000597	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.96e-05	0.000586	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A2—Metabolism—ALB—multiple sclerosis	4.88e-05	0.000577	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Generic Transcription Pathway—MYC—multiple sclerosis	4.83e-05	0.000571	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.56e-05	0.000539	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.43e-05	0.000524	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	4.29e-05	0.000507	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	4.29e-05	0.000507	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.16e-05	0.000492	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—ALB—multiple sclerosis	4.12e-05	0.000487	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—APOE—multiple sclerosis	4.01e-05	0.000474	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—BCHE—multiple sclerosis	3.93e-05	0.000465	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—GPC5—multiple sclerosis	3.92e-05	0.000464	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.81e-05	0.00045	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—APOE—multiple sclerosis	3.64e-05	0.00043	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.56e-05	0.000421	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.47e-05	0.000411	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—POMC—multiple sclerosis	3.45e-05	0.000408	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—IL2—multiple sclerosis	3.34e-05	0.000395	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.3e-05	0.00039	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—BCHE—multiple sclerosis	3.28e-05	0.000388	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—RRM1—multiple sclerosis	3.25e-05	0.000384	CbGpPWpGaD
Ursodeoxycholic acid—SLC10A1—Metabolism—ALB—multiple sclerosis	3.14e-05	0.000372	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—POMC—multiple sclerosis	3.13e-05	0.00037	CbGpPWpGaD
Ursodeoxycholic acid—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.01e-05	0.000355	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Metabolism—ALB—multiple sclerosis	2.85e-05	0.000337	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—TGFB1—multiple sclerosis	2.6e-05	0.000308	CbGpPWpGaD
Ursodeoxycholic acid—ABCC4—Hemostasis—MAPK1—multiple sclerosis	2.55e-05	0.000302	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—APOE—multiple sclerosis	2.37e-05	0.00028	CbGpPWpGaD
Ursodeoxycholic acid—NR1H4—Gene Expression—MYC—multiple sclerosis	2.32e-05	0.000275	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—POMC—multiple sclerosis	2.03e-05	0.00024	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—APOE—multiple sclerosis	1.97e-05	0.000233	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.87e-05	0.000221	CbGpPWpGaD
Ursodeoxycholic acid—ABCB11—Metabolism—ALB—multiple sclerosis	1.85e-05	0.000219	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—POMC—multiple sclerosis	1.7e-05	0.000201	CbGpPWpGaD
Ursodeoxycholic acid—SLCO1A2—Metabolism—ALB—multiple sclerosis	1.55e-05	0.000183	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—APOE—multiple sclerosis	1.12e-05	0.000133	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—POMC—multiple sclerosis	9.64e-06	0.000114	CbGpPWpGaD
Ursodeoxycholic acid—CYP2E1—Metabolism—ALB—multiple sclerosis	8.79e-06	0.000104	CbGpPWpGaD
